508 related articles for article (PubMed ID: 3886702)
21. Insulin dose response analysis of free fatty acid kinetics.
Jensen MD; Nielsen S
Metabolism; 2007 Jan; 56(1):68-76. PubMed ID: 17161228
[TBL] [Abstract][Full Text] [Related]
22. Metabolic effects of liver transplantation in cirrhotic patients.
Luzi L; Perseghin G; Regalia E; Sereni LP; Battezzati A; Baratti D; Bianchi E; Terruzzi I; Hilden H; Groop LC; Pulvirenti A; Taskinen MR; Gennari L; Mazzaferro V
J Clin Invest; 1997 Feb; 99(4):692-700. PubMed ID: 9045872
[TBL] [Abstract][Full Text] [Related]
23. Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity.
Freymond D; Bogardus C; Okubo M; Stone K; Mott D
J Clin Invest; 1988 Nov; 82(5):1503-9. PubMed ID: 2846655
[TBL] [Abstract][Full Text] [Related]
24. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.
Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA
Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111
[TBL] [Abstract][Full Text] [Related]
25. Regulation of glucose metabolism by free fatty acid availability in septic and nonseptic rats.
Lang CH; Dobrescu C
Circ Shock; 1992 Oct; 38(2):91-102. PubMed ID: 1423926
[TBL] [Abstract][Full Text] [Related]
26. Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo.
Jenkins AB; Storlien LH; Chisholm DJ; Kraegen EW
J Clin Invest; 1988 Jul; 82(1):293-9. PubMed ID: 3292587
[TBL] [Abstract][Full Text] [Related]
27. Interactions of insulin and epinephrine in human metabolism: their influence on carbohydrate and lipid oxidation rate.
Müller-Hess R; Geser CA; Pittet P; Chappuis P; Jéquier E; Felber JP
Diabete Metab; 1975 Sep; 1(3):151-7. PubMed ID: 1234578
[TBL] [Abstract][Full Text] [Related]
28. Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis.
Petrides AS; Luzi L; Reuben A; Riely C; DeFronzo RA
Hepatology; 1991 Sep; 14(3):432-41. PubMed ID: 1874488
[TBL] [Abstract][Full Text] [Related]
29. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons.
Lillioja S; Foley J; Bogardus C; Mott D; Howard BV
Metabolism; 1986 Jun; 35(6):505-14. PubMed ID: 3713512
[TBL] [Abstract][Full Text] [Related]
30. [Thermic and metabolic effects of meals in liver cirrhosis assessment of oxidation and storage rates of nutrients].
Campillo B; Bories P; Devanlay M; Wirquin E; Pornin B; Sommer F; Fouet P
Gastroenterol Clin Biol; 1990; 14(8-9):655-61. PubMed ID: 2227238
[TBL] [Abstract][Full Text] [Related]
31. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity.
Groop LC; Bonadonna RC; Simonson DC; Petrides AS; Shank M; DeFronzo RA
Am J Physiol; 1992 Jul; 263(1 Pt 1):E79-84. PubMed ID: 1636701
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in essential hypertension.
Ferrannini E; Buzzigoli G; Bonadonna R; Giorico MA; Oleggini M; Graziadei L; Pedrinelli R; Brandi L; Bevilacqua S
N Engl J Med; 1987 Aug; 317(6):350-7. PubMed ID: 3299096
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.
Meex RC; Phielix E; Moonen-Kornips E; Schrauwen P; Hesselink MK
J Clin Endocrinol Metab; 2011 May; 96(5):1415-23. PubMed ID: 21289240
[TBL] [Abstract][Full Text] [Related]
34. Resistance to insulin mediated glucose disposal in obese subjects: respective effect of lipid metabolism and glycemia.
Felley CP; Kleiber H; van Melle GD; Frascarolo P; Jéquier E; Felber JP
Int J Obes Relat Metab Disord; 1992 Mar; 16(3):185-91. PubMed ID: 1317827
[TBL] [Abstract][Full Text] [Related]
35. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.
Groop LC; Bonadonna RC; Shank M; Petrides AS; DeFronzo RA
J Clin Invest; 1991 Jan; 87(1):83-9. PubMed ID: 1985114
[TBL] [Abstract][Full Text] [Related]
36. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
[TBL] [Abstract][Full Text] [Related]
37. Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men.
Åberg V; Thörne A; Alvestrand A; Nordenström J
Metabolism; 2012 Feb; 61(2):221-8. PubMed ID: 21864866
[TBL] [Abstract][Full Text] [Related]
38. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Groop LC; Bonadonna RC; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo RA
J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of insulin resistance after kidney transplantation.
Ekstrand A; Ahonen J; Grönhagen-Riska C; Groop L
Transplantation; 1989 Oct; 48(4):563-8. PubMed ID: 2678633
[TBL] [Abstract][Full Text] [Related]
40. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
